← Leaderboards
David Ross
University Of Colorado Denver
$13,236,658
Attributed
$15,228,690
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–21$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$15,228,690 · 10
By mechanism
R01$13,240,468 · 6
P50$1,392,398 · 2
R21$595,824 · 2
Top collaborators
- Rafael De Cabo5 shared
- Kristofer S Fritz5 shared
- Dan Theodorescu5 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Jonathan A Doorn$4,044,527
- Brian M Freed$1,999,717
- Cynthia Ju$12,650,556
Others in their field
Top investigators on “Quinones”
- Judith Pollock Klinman · University Of California Berkeley$13,791,382
- Carrie Van Doren Breton · University Of Southern California$13,157,577
- Anil Kumar Jaiswal · Baylor College Of Medicine$12,318,169
- Frank D. Gilliland · University Of Southern California$11,525,291
- Judy L. Bolton · University Of Illinois At Chicago$9,786,820
- Takao Yagi · Scripps Research Institute$8,738,476
Research focus
QuinonesProteinsInhibitor/AntagonistResponseBaseCellsNqo1 GeneEnzymesEnzyme ActivityIn VivoGrowthGenerationsIn VitroCell LineMolecular ConformationMalignant Neoplasm Of PancreasStructureTumorBiochemicalSuicide InhibitorMolecularHuman TissueDesignMediating
Grant awards (49)
Regulation of insulin signaling and sensitivity by the xenobiotic metabolizing enzyme NQO1$388,750
R01 · FY2021 · DK · contact PI
Regulation of insulin signaling and sensitivity by the xenobiotic metabolizing enzyme NQO1$388,750
R01 · FY2020 · DK · contact PI
Regulation of insulin signaling and sensitivity by the xenobiotic metabolizing enzyme NQO1$388,750
R01 · FY2019 · DK · contact PI
Regulation of insulin signaling and sensitivity by the xenobiotic metabolizing enzyme NQO1$388,750
R01 · FY2018 · DK · contact PI
Regulation of insulin signaling and sensitivity by the xenobiotic metabolizing enzyme NQO1$388,750
R01 · FY2017 · DK · contact PI
Biochemical and molecular studies on NQO1. Design of less toxic Hsp90 inhibitors$312,983
R01 · FY2017 · CA · contact PI
Biochemical and molecular studies on NQO1. Design of less toxic Hsp90 inhibitors$312,983
R01 · FY2016 · CA · contact PI
Targeting Ral GTPases in Bladder Cancer$300,891
P50 · FY2016 · CA
Biochemical and molecular studies on NQO1. Design of less toxic Hsp90 inhibitors$312,470
R01 · FY2015 · CA · contact PI
Targeting Ral GTPases in Bladder Cancer$303,014
P50 · FY2015 · CA
Novel Mechanisms of Quinone Toxicity$334,243
R01 · FY2014 · ES · contact PI
Biochemical and molecular studies on NQO1. Design of less toxic Hsp90 inhibitors$304,864
R01 · FY2014 · CA · contact PI
Targeting Ral GTPases in Bladder Cancer$294,792
P50 · FY2014 · CA
Novel Mechanisms of Quinone Toxicity$330,865
R01 · FY2013 · ES · contact PI
Biochemical and molecular studies on NQO1. Design of less toxic Hsp90 inhibitors$323,289
R01 · FY2013 · CA · contact PI
Targeting Ral GTPases in Bladder Cancer$290,501
P50 · FY2013 · CA
Novel Mechanisms of Quinone Toxicity$337,802
R01 · FY2012 · ES · contact PI
Targeting Ral GTPases in Bladder Cancer$203,200
P50 · FY2012 · CA
Novel Mechanisms of Quinone Toxicity$337,889
R01 · FY2011 · ES · contact PI
Novel Mechanisms of Quinone Toxicity$341,480
R01 · FY2010 · ES · contact PI
Biochemical and Molecular Studies on DT Diaphorase$323,378
R01 · FY2010 · CA · contact PI
Targeting of NQ02 in CML$191,250
R21 · FY2010 · HL · contact PI
Biochemical and Molecular Studies on DT Diaphorase$323,691
R01 · FY2009 · CA · contact PI
Targeting of NQ02 in CML$230,250
R21 · FY2009 · HL · contact PI
Biochemical and Molecular Studies on DT Diaphorase$323,993
R01 · FY2008 · CA · contact PI
NQO1 Inhibitors and Pancreatic Cancer Therapy$259,550
R01 · FY2008 · CA · contact PI
Biochemical and Molecular Studies on DT Diaphorase$324,284
R01 · FY2007 · CA · contact PI
NQO1 in Protection Against Benzene Toxicicity$292,040
R01 · FY2007 · ES · contact PI
NQO1 Inhibitors and Pancreatic Cancer Therapy$259,550
R01 · FY2007 · CA · contact PI
NQ01, Oxidative Stress and Proteasomal Inhibition$357,155
R01 · FY2006 · NS · contact PI
Biochemical and Molecular Studies on DT Diaphorase$334,256
R01 · FY2006 · CA · contact PI
NQO1 in Protection Against Benzene Toxicicity$300,762
R01 · FY2006 · ES · contact PI
NQO1 Inhibitors and Pancreatic Cancer Therapy$267,302
R01 · FY2006 · CA · contact PI
NQ01, Oxidative Stress and Proteasomal Inhibition$365,750
R01 · FY2005 · NS
BIOCHEMICAL AND MOLECULAR STUDIES ON DT DIAPHORASE$341,621
R01 · FY2005 · CA
NQO1 in Protection Against Benzene Toxicicity$308,000
R01 · FY2005 · ES
NQO1 Inhibitors and Pancreatic Cancer Therapy$273,735
R01 · FY2005 · CA
NQ01, Oxidative Stress and Proteasomal Inhibition$365,750
R01 · FY2004 · NS
BIOCHEMICAL AND MOLECULAR STUDIES ON DT DIAPHORASE$331,672
R01 · FY2004 · CA
NQO1 in Protection Against Benzene Toxicicity$306,834
R01 · FY2004 · ES
Protective Role of Mitochondrial Vitamin E in Parkinson$174,324
R21 · FY2004 · NS
NQ01, Oxidative Stress and Proteasomal Inhibition$363,375
R01 · FY2003 · NS
BIOCHEMICAL AND MOLECULAR STUDIES ON DT DIAPHORASE$322,012
R01 · FY2003 · CA
NQO1 in Protection Against Benzene Toxicicity$303,666
R01 · FY2003 · ES
NQ01, Oxidative Stress and Proteasomal Inhibition$344,090
R01 · FY2002 · NS
BIOCHEMICAL AND MOLECULAR STUDIES ON DT DIAPHORASE$312,633
R01 · FY2002 · CA
BIOCHEMICAL AND MOLECULAR STUDIES ON DT DIAPHORASE$303,527
R01 · FY2001 · CA
BIOCHEMICAL AND MOLECULAR STUDIES ON DT-DIAPHORASE$236,064
R01 · FY2000 · CA
NQ01 IN PROTECTION AGAINST BENZENE TOXICITY$203,160
R01 · FY2000 · ES